Contrast-Enhanced Magnetic Resonance Body Imaging

Topics in Magnetic Resonance Imaging

Volumn 14, Issue 5, 2003, Pages 403-425

  Schneider, Guenther ^a   Uder, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Body imaging; Contrast agents; Liver imaging; Pelvic imaging

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBENIC ACID; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ABDOMEN; ADRENAL CANCER; ANGIOMYOLIPOMA; BREAST CARCINOMA; BREAST DISEASE; CONTRAST ENHANCEMENT; CROHN DISEASE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL DISEASE; HODGKIN DISEASE; HUMAN; JAUNDICE; KIDNEY CARCINOMA; KIDNEY DISEASE; LIVER ADENOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TUMOR; LUNG CARCINOMA; LUNG DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MEDIASTINUM; MEDIASTINUM TUMOR; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TUMOR; PANCREAS TUMOR; PELVIS; PELVIS TUMOR; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PYELONEPHRITIS; REVIEW; THORAX; THORAX WALL; TUMOR DIAGNOSIS; UROGRAPHY; UTERINE CERVIX CANCER; UTERUS MYOMA;

ABDOMEN; BREAST DISEASES; CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; NEOPLASMS; PELVIS; THORAX;

EID: 0347504945     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-200310000-00006     Document Type: Review

References (51)

1. Heywang SH, Bassermann R, Fenzl G, et al. MRI of the breast: histopathologic correlation. Eur J Radiol. 1987;7:175-182.
2. Boetes C, Mus RD, Hollands R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and ultrasound demonstrating extent. Radiology. 1995;197:743-747.
3. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology. 1994;193:777-781.
4. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220:13-30.
5. Hylton NM, Frankel SD. Imaging techniques for breast MR imaging. Magn Reson Imaging Clin North Am. 1994;2:511-525.
6. Hylton NM, Kinkel K. Technical aspects of breast magnetic resonance imaging. Top Magn Reson Imaging. 1998;9:3-16.
7. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without GD-DTPA. Preliminary observations. Radiology. 1989;170:681-686.
8. Leong CS, Daniel BL, Herfkens RJ, et al. Characterization of breast lesion morphology with delayed 3DSSMT: an adjunct to dynamic breast MRI. J Magn Reson Imaging. 2000;11:87-96.
9. Kinkel K, Hylton NM. Challenges to interpretation of breast MRI. J Magn Reson Imaging. 2001;13:821-829.
10. Mussurakis S, Gibbs P, Horsman A. Peripheral enhancement and spatial contrast uptake heterogeneity of primary breast tumours: quantitative assessment with dynamic MRI. J Comput Assist Tomogr. 1998;22:35-46.
11. Kelcz F, Santyr G. Gadolinium-enhanced breast MRI. Crit Rev Diagn Imaging. 1995;36:287-338.
12. Heywang-Köbrunner SH, Blick U, Bradley WG, et al. International investigation of breast MRI: results of a multicenter study (11 sites) concerning diagnostic parameters of contrast enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol. 2001;11:531-546.
13. Van Ongeval C. MR imaging of the breast: present indications. organe de la societe royale belge de radiologie. 2000;83:80-84.
14. Erasmus JJ, McAdams HP, Donnelly LF, et al. MR imaging of mediastinal masses. Magn Reson Imaging Clin North Am. 2000;8:59-89.
15. Lanzer P, Barta C, Botvinick EH, et al. ECG-synchronized cardiac MR imaging: method and evaluation. Radiology. 1985;155:681-686.
16. Thompson BH, Stanford W. MR imaging of pulmonary and mediastinal malignancies. Magn Reson Imaging Clin North Am. 2000;8:729-739.
17. Obuchowski AM, Ortiz AO. MR imaging of the thoracic inlet. Magn Reson Imaging Clin North Am. 2000;8:183-203.
18. Benson L, Hemmingsson A, Ericsson A, et al. Magnetic resonance imaging in primary amyloidosis. Acta Radiol. 1987;28:13.
19. Barish MA, Jara H. Motion artifact control in body MR imaging. Magn Reson Imaging Clin North Am. 1999;7:289-301.
20. Ferrucci JT. Advances in abdominal MR imaging. Radiographics. 1998;18:1569-1586.
21. Mitchell DG. Fast MR imaging techniques: impact in the abdomen. J Magn Reson Imaging. 1996;6:812-821.
22. Tang Y, Yamashita Y, Takahashi M. Ultrafast T2-weighted imaging of the abdomen and pelvis: use of single shot fast spin-echo imaging. J Magn Reson Imaging. 1998;8:384-390.
23. Laing AD, Gibson RN. Magnetic resonance cholangiopancreatography. Australas Radiol. 1999;43:284-293.
24. Siegelman ES. MR imaging of diffuse liver disease: hepatic fat and iron. Magn Reson Imaging Clin North Am. 1997;5:347-365.
25. Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology. 2001;218:27-38.
26. Ito K, Honjo K, Fujita T, et al. Hepatic parenchymal hyperperfusion abnormalities detected with multisection dynamic MR imaging: appearance and interpretation. J Magn Reson Imaging. 1996;6:861-867.
27. Gehl HB, Bourne M, Grazioli L, et al. Off-site evaluation of liver lesion detection by Gd-BOPTA-enhanced MR imaging. Eur Radiol. 2001;11:187-192.
28. Runge VM, Kenney CM. Phase II double-blind, dose-ranging clinical evaluation of gadobenate dimeglumine in focal liver lesions: with analysis of liver and kidney signal change on early and delayed imaging. J Magn Reson Imaging. 2000;11:655-664.
29. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology. 1999;212:876-884.
30. Little AF, Smith PJ, Lee WK, et al. Imaging of the normal and abnormal pancreaticobiliary system with single-shot MR cholangiopancreaticography: a pictorial review. Austarlas Radiol. 1999;43:427-434.
31. Kettritz U, Warshauer DM, Brown ED, et al. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. Eur Radiol. 1996;6:14-18.
32. Martin DR, Semelka RC. MR imaging of pancreatic masses. Magn Reson Imaging Clin North Am. 2000;8:787-812.
33. Siegelman ES. MR imaging of the adrenal neoplasms. Magn Reson Imaging Clin North Am. 2000;8:769-786.
34. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology. 1996;200:743-747.
35. Chung JJ, Semelka RC, Martin DR. Adrenal adenomas: characteristic postgadolinium capillary blush on dynamic MR imaging. J Magn Reson Imaging. 2001;13:242-248.
36. Davidson AJ, Hartman DS, Choyke PL, et al. Radiologic assessment of renal masses: implications for patient care. Radiology. 1997;202:297-305.
37. Yamashita Y, Miyazaki T, Hatanaka Y, et al. Dynamic MRI of small renal cell carcinoma. J Comput Assist Tomogr. 1995;19:759-765.
38. Gilfeather M, Woodward PJ. MR imaging of the adrenal glands and kidneys. Semin Ultrasound CT MR. 1998;19:53-66.
39. Kreft BP, Muller-Miny H, Sommer T, et al. Diagnostic value of MR imaging in comparison to CT in the detection and differential diagnosis of renal masses: ROC analysis. Eur Radiol. 1997;7:542-547.
40. Blandino A, Gaeta M, Minutoli F, et al. MR urography of the ureter. AJR Am J Roentgenol. 2002;179:1307-1314.
41. El-Diasty T, Mansour O, Farouk A. Diuretic contrast-enhanced magnetic resonance urography versus intravenous urography for depiction of nondilated urinary tracts. Abdom Imaging. 2003;28:135-145.
42. Nolte-Ernsting CC, Staatz G, Tacke J, et al. MR urography today. Abdom Imaging. 2003;28:191-209.
43. Rieber A, Aschoff A, Nussle K, et al. MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol. 2000;10:1377-1382.
44. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. MR enteroclysis: technical considerations and clinical applications. Eur Radiol. 2002;12:2651-2658.
45. Debatin JF, Lauenstein TC. Virtual magnetic resonance colonography. Gut. 2003;52(suppl 4):17-22.
46. Brizi MG, Minordi LM, Mirk P, et al. The state of the art of small bowel imaging: combine the old with the new. Rays. 2002;27:51-65.
47. Robinson P, Carrington BM, Swindell R, et al. O'Dwyer ST. Recurrent or residual pelvic bowel cancer: accuracy of MRI local extent before salvage surgery. Clin Radiol. 2002;57:514-522.
48. Kennedy AM, Gilfeather MR, Woodward PJ. MRI of the female pelvis. Semin Ultrasound CT MR. 1999;20:214-230.
49. Outwater E, Kressel HY. Evaluation of gynecologic malignancy by magnetic resonance imaging. Radiol Clin North Am. 1992;30:789-806.
50. Scheidler J, Reiser MF. MRI of the female and male pelvis: current and future applications of contrast enhancement. Eur J Radiol. 2000;34:220-228.
51. Lipson SA, Hricak H. MR imaging of the female pelvis. Radiol Clin North Am. 1996;34:1157-1182.